Healthcare provider profile · identity verified

Paul Michael Pelletier, M.D.

Family Practice · EAGLE LAKE, ME · NPI 1689699852

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	602	144
Levothyroxine Sodium	Levothyroxine Sodium	360	68
Eliquis	Apixaban	268	44
Lisinopril	Lisinopril	234	49
Amlodipine Besylate	Amlodipine Besylate	227	59
Metoprolol Succinate	Metoprolol Succinate	221	52
Pantoprazole Sodium	Pantoprazole Sodium	213	51
Omeprazole	Omeprazole	187	33
Furosemide	Furosemide	185	37
Gabapentin	Gabapentin	183	28
Metformin Hcl	Metformin Hcl	169	29
Tamsulosin Hcl	Tamsulosin Hcl	158	30
Potassium Chloride	Potassium Chloride	153	27
Losartan Potassium	Losartan Potassium	151	34
Jardiance	Empagliflozin	147	33
Albuterol Sulfate Hfa	Albuterol Sulfate	125	45
Famotidine	Famotidine	118	32
Hydrochlorothiazide	Hydrochlorothiazide	116	28
Trazodone Hcl	Trazodone Hcl	114	25
Finasteride	Finasteride	113	18
Glipizide	Glipizide	112	18
Prednisone	Prednisone	109	40
Simvastatin	Simvastatin	104	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	26
Rosuvastatin Calcium	Rosuvastatin Calcium	99	28
Trulicity	Dulaglutide	96	14
Citalopram Hbr	Citalopram Hydrobromide	95	18
Pregabalin	Pregabalin	94	19
Carvedilol	Carvedilol	93	26
Metoprolol Tartrate	Metoprolol Tartrate	93	22
Olanzapine	Olanzapine	87	suppressed
Tramadol Hcl	Tramadol Hcl	82	23
Montelukast Sodium	Montelukast Sodium	80	16
Metformin Hcl Er	Metformin Hcl	74	22
Sertraline Hcl	Sertraline Hcl	73	19
Breo Ellipta	Fluticasone/Vilanterol	70	11
Clopidogrel	Clopidogrel Bisulfate	70	16
Levetiracetam	Levetiracetam	70	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	69	16
Spironolactone	Spironolactone	69	15
Triamcinolone Acetonide	Triamcinolone Acetonide	69	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	15
Allopurinol	Allopurinol	61	15
Clotrimazole	Clotrimazole	60	24
Arexvy	Rsvpref3 Antigen/As01e/Pf	55	55
Mirtazapine	Mirtazapine	55	12
Warfarin Sodium	Warfarin Sodium	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Propranolol Hcl	Propranolol Hcl	49	suppressed
Methenamine Hippurate	Methenamine Hippurate	44	suppressed
Baclofen	Baclofen	43	suppressed
Myrbetriq	Mirabegron	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	14
Bumetanide	Bumetanide	38	suppressed
Celecoxib	Celecoxib	38	11
Ketoconazole	Ketoconazole	38	12
Atenolol	Atenolol	37	11
Glipizide Er	Glipizide	37	11
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	14
Doxycycline Hyclate	Doxycycline Hyclate	35	22
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Meloxicam	Meloxicam	34	suppressed
Meclizine Hcl	Meclizine Hcl	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	12
Telmisartan	Telmisartan	32	suppressed
Lamotrigine	Lamotrigine	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Morphine Sulfate	Morphine Sulfate	28	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ozempic	Semaglutide	26	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	25	25
Lacosamide	Lacosamide	24	suppressed
Methotrexate	Methotrexate Sodium	24	suppressed
Sotalol	Sotalol Hcl	24	suppressed
Digoxin	Digoxin	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	11
Rybelsus	Semaglutide	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Nystop	Nystatin	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	18
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Nitroglycerin	Nitroglycerin	20	14
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	13
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Risperidone	Risperidone	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	14	suppressed
Cefdinir	Cefdinir	14	12
Diazepam	Diazepam	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Lactulose	Lactulose	14	suppressed
Novolog	Insulin Aspart	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Clozapine	Clozapine	13	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Orencia	Abatacept	13	suppressed
Osphena	Ospemifene	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Topiramate Er	Topiramate	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Paroxetine Er	Paroxetine Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Vyndamax	Tafamidis	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error